[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

GE Healthcare Technologies (GEHC)

GE Healthcare Technologies (GEHC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

Is DexCom Stock Underperforming the Dow?

Valued at a market cap of $28 billion, San Diego, California-based DexCom, Inc. (DXCM) is a medical device company that focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. 

Companies with a market cap of $10 billion or more are typically referred to as “big-cap stocks.” DXCM fits squarely into that category, with its market cap exceeding this threshold and reflecting its substantial size and influence in the medical devices industry.     

Fundamentals

See More
  • Market Capitalization, $K 29,417,864
  • Shares Outstanding, K 454,892
  • Annual Sales, $ 20,625 M
  • Annual Income, $ 2,084 M
  • EBIT $ 2,649 M
  • EBITDA $ 3,227 M
  • 60-Month Beta 0.74
  • Price/Sales 1.41
  • Price/Cash Flow 10.86
  • Price/Book 2.72

Options Overview Details

View History
  • Implied Volatility 36.39% (+2.73%)
  • Historical Volatility 49.07%
  • IV Percentile 76%
  • IV Rank 67.85%
  • IV High 42.42% on 10/07/25
  • IV Low 23.65% on 12/23/25
  • Expected Move (DTE 5) 2.19 (3.39%)
  • Put/Call Vol Ratio 0.37
  • Today's Volume 1,161
  • Volume Avg (30-Day) 8,451
  • Put/Call OI Ratio 0.58
  • Today's Open Interest 65,467
  • Open Int (30-Day) 164,488
  • Expected Range 62.48 to 66.86

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 19 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $1.04
  • Number of Estimates 6
  • High Estimate $1.06
  • Low Estimate $1.02
  • Prior Year $1.06
  • Growth Rate Est. (year over year) -1.89%

Price Performance

See More
Period Period Low Period High Performance
1-Month
60.67 +6.59%
on 05/15/26
65.63 -1.46%
on 05/27/26
+3.63 (+5.95%)
since 05/05/26
3-Month
58.75 +10.08%
on 04/29/26
76.28 -15.22%
on 03/06/26
-12.44 (-16.13%)
since 03/05/26
52-Week
58.75 +10.08%
on 04/29/26
89.77 -27.96%
on 01/08/26
-6.88 (-9.62%)
since 06/05/25

Most Recent Stories

More News
Is DexCom Stock Underperforming the Dow?

DexCom has lagged behind the Dow Jones over the past year, yet analysts remain highly bullish about the stock’s outlook.

GEHC : 64.67 (+1.35%)
$DOWI : 50,866.78 (-1.35%)
DXCM : 72.86 (+0.37%)
GE HealthCare receives FDA 510(k) clearance for MIM Contour ProtégéAI+ 2.0, advancing AI-enabled radiation therapy planning with expanded clinical capabilities

Marking the evolution of MIM AI-enabled auto-contouring software, MIM Contour ProtégéAI+ 2.0 introduces new models, including a Magnetic Resonance (MR) Brain model, as well as an updated Computed Tomography...

GEHC : 64.67 (+1.35%)
3 Value Stocks with Questionable Fundamentals

3 Value Stocks with Questionable Fundamentals

XPOF : 5.34 (-2.55%)
BBY : 71.54 (+0.77%)
GEHC : 64.67 (+1.35%)
GE HealthCare Focuses on Expanding Access to Nuclear Medicine Through AI, Radiopharmaceutical and Imaging Innovations

Nuclear medicine is reaching an inflection point as advances in imaging, theranostics and radiopharmaceuticals help accelerate clinical adoption At #SNMMI26, GE HealthCare is showcasing...

GEHC : 64.67 (+1.35%)
1 S&P 500 Stock on Our Buy List and 2 We Question

1 S&P 500 Stock on Our Buy List and 2 We Question

SYF : 70.84 (+0.08%)
GEHC : 64.67 (+1.35%)
ON : 117.26 (-11.05%)
GE HealthCare Technologies Inc. (GEHC) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

Law Offices of Howard G. Smith continues its investigation on behalf of GE HealthCare Technologies Inc. (“GE HealthCare” or the “Company”) (NASDAQ: GEHC ) investors concerning the...

GEHC : 64.67 (+1.35%)
Securities Fraud Investigation Into GE HealthCare Technologies Inc. (GEHC) Continues – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

The Law Offices of Frank R. Cruz continues its investigation of GE HealthCare Technologies Inc. (“GE HealthCare” or the “Company”) (NASDAQ: GEHC ) on behalf of investors...

GEHC : 64.67 (+1.35%)
Securities Fraud Investigation Into GE HealthCare Technologies Inc. (GEHC) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

Glancy Prongay Wolke & Rotter LLP , a leading national shareholder rights law firm, continues its investigation on behalf of GE HealthCare Technologies Inc. (“GE HealthCare” or the “Company”)...

GEHC : 64.67 (+1.35%)
GEHC INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving GE HealthCare Technologies Inc.

The law firm of Kirby McInerney LLP continues its investigation on behalf of GE HealthCare Technologies Inc. (“GE HealthCare” or the “Company”) (NASDAQ:GEHC) investors concerning...

GEHC : 64.67 (+1.35%)
Securities Fraud Investigation Into GE HealthCare Technologies Inc. (GEHC) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

Glancy Prongay Wolke & Rotter LLP , a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of GE HealthCare Technologies Inc. (“GE HealthCare”...

GEHC : 64.67 (+1.35%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength just crossed above 50%. The market is indicating support for a bullish trend.

See More Share

Business Summary

Chicago, IL-based GE Healthcare is a leading maker of medical imaging and patient-monitoring products and related equipment and services. Approximately half of GE Healthcare's revenue comes from equipment sales, with consumables and services accounting for the other half. GE Healthcare started operating...

See More

Key Turning Points

3rd Resistance Point 66.31
2nd Resistance Point 65.54
1st Resistance Point 65.11
Last Price 64.67
1st Support Level 63.91
2nd Support Level 63.14
3rd Support Level 62.71

See More

52-Week High 89.77
Fibonacci 61.8% 77.92
Fibonacci 50% 74.26
Fibonacci 38.2% 70.60
Last Price 64.67
52-Week Low 58.75

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.